Gauri Bhosale

Gauri Bhosale is a Scientist II at Astellas Pharma, specializing in engineered small molecules since April 2024. Concurrently, Gauri serves as a Research Scientist at Nanna Therapeutics, starting from September 2021. Prior experience includes a role as a Research Associate at UCL from April 2018 to June 2021, focusing on the Sigma-1 receptor's impact on mitochondrial function in sensory neurons, with funding from Mundipharma. Gauri holds a PhD in Mitochondrial Biology and an MSc in Genetics of Human Disease from UCL, along with a Bachelor's degree in Natural Sciences (Genetics) from the University of Cambridge.